{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:17:09Z","timestamp":1784809029929,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":6515,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.micinf.2005.10.004","type":"journal-article","created":{"date-parts":[[2006,1,14]],"date-time":"2006-01-14T07:17:25Z","timestamp":1137223045000},"page":"810-822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis"],"prefix":"10.1016","volume":"8","author":[{"given":"Eva","family":"P\u00e9rez-Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Kochan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Magdalena","family":"Gherardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2005.10.004_bib1","unstructured":"World Health Organization, Leishmania\/HIV Co-infection in South-Western Europe 1990-1998: Retrospective Analysis of 965 Cases, Geneve, WHO\/LEISH\/2000 42 (2000) 1\u201312."},{"key":"10.1016\/j.micinf.2005.10.004_bib2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4269\/ajtmh.1998.58.436","article-title":"Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain","volume":"58","author":"Lopez-Velez","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.micinf.2005.10.004_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4269\/ajtmh.1996.55.273","article-title":"Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting","volume":"55","author":"Berrahal","year":"1996","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.micinf.2005.10.004_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-4017(00)00223-5","article-title":"The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection","volume":"90","author":"Solano-Gallego","year":"2000","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.micinf.2005.10.004_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-9292-2-14","article-title":"Physiological consequences of drug resistance in Leishmania and their relevance for chemotherapy","volume":"2","author":"Ponte-Sucre","year":"2003","journal-title":"Kinetoplastid Biol. Dis."},{"key":"10.1016\/j.micinf.2005.10.004_bib6","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/AAC.47.5.1529-1535.2003","article-title":"The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis","volume":"47","author":"Carter","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micinf.2005.10.004_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/bj20021684","article-title":"Role of superoxide dismutase in survival of Leishmania within the macrophage","volume":"369","author":"Ghosh","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.micinf.2005.10.004_bib8","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.vaccine.2003.10.046","article-title":"A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major","volume":"22","author":"Ahmed","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2005.10.004_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7725103","article-title":"Expression cloning of a protective Leishmania antigen","volume":"268","author":"Mougneau","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.micinf.2005.10.004_bib10","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1128\/IAI.67.7.3641-3644.1999","article-title":"CD4 (+) T cells which react to the Leishmania major LACK antigen rapidly secrete interleukin-4 and are detrimental to the host in resistant B10.D2 mice","volume":"67","author":"Julia","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2005.10.004_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.7904381","article-title":"The adjuvant effect of interleukin-12 in a vaccine against Leishmania major","volume":"263","author":"Afonso","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.micinf.2005.10.004_bib12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","article-title":"Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major","volume":"186","author":"Gurunathan","year":"1997","journal-title":"J. Exp. Med."},{"issue":"Pt 1","key":"10.1016\/j.micinf.2005.10.004_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/icb.1988.7","article-title":"Resistance to cutaneous leishmaniasis in nude mice injected with L3T4+T cells but not with Ly-2+T cells","volume":"66","author":"Moll","year":"1988","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.micinf.2005.10.004_bib14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.0141-9838.2004.00668.x","article-title":"Cross-talk between CD8 (+) and CD4 (+) T cells in experimental cutaneous leishmaniasis: CD8 (+) T cells are required for optimal IFN-gamma production by CD4 (+) T cells","volume":"25","author":"Herath","year":"2003","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.micinf.2005.10.004_bib15","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.micinf.2005.10.004_bib16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4049\/jimmunol.144.3.1075","article-title":"Protection against Leishmania major in BALB\/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes","volume":"144","author":"Scott","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.micinf.2005.10.004_bib17","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.168.5.1675","article-title":"Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens","volume":"168","author":"Scott","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.micinf.2005.10.004_bib18","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.4049\/jimmunol.147.5.1653","article-title":"Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines","volume":"147","author":"Holaday","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.micinf.2005.10.004_bib19","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0264-410X(98)00355-7","article-title":"A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation","volume":"17","author":"Caver","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2005.10.004_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-2478(98)00164-3","article-title":"Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS","volume":"66","author":"Hanke","year":"1999","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.micinf.2005.10.004_bib21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0264-410X(98)00238-2","article-title":"Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime","volume":"17","author":"Hanke","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2005.10.004_bib22","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.1128\/JVI.72.12.10180-10188.1998","article-title":"Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus","volume":"72","author":"Kent","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.micinf.2005.10.004_bib23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/8406","article-title":"Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations","volume":"5","author":"Robinson","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.micinf.2005.10.004_bib24","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.1073\/pnas.95.13.7648","article-title":"Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine","volume":"95","author":"Sedegah","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.micinf.2005.10.004_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/intimm\/14.1.31","article-title":"Prime-boost immunization generates a high frequency, high-avidity CD8 (+) cytotoxic T lymphocyte population","volume":"14","author":"Estcourt","year":"2002","journal-title":"Int. Immunol."},{"key":"10.1016\/j.micinf.2005.10.004_bib26","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0264-410X(01)00427-3","article-title":"A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36\/LACK antigen protects BALB\/c mice from cutaneous leishmaniasis","volume":"20","author":"Gonzalo","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2005.10.004_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/viro.2000.0792","article-title":"A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8 (+) T cells","volume":"280","author":"Zavala","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2005.10.004_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-5699(00)01612-1","article-title":"The prime-boost strategy: exciting prospects for improved vaccination","volume":"21","author":"Ramshaw","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.micinf.2005.10.004_bib29","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2005.10.004_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1286-4579(02)00077-1","article-title":"The combination of DNA vectors expressing IL-12+ IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36\/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36\/LACK","volume":"5","author":"Tapia","year":"2003","journal-title":"Microbes. Infect."},{"key":"10.1016\/j.micinf.2005.10.004_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/1568005033481123","article-title":"Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery","volume":"3","author":"Sutter","year":"2003","journal-title":"Curr. Drug. Targets Infect. Disord."},{"issue":"Pt 5","key":"10.1016\/j.micinf.2005.10.004_bib32","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J. Gen. Virol."},{"issue":"Pt 5","key":"10.1016\/j.micinf.2005.10.004_bib33","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"Blanchard","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.micinf.2005.10.004_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF01311113","article-title":"Partial deletion of the human host range gene in the attenuated vaccinia virus MVA","volume":"105","author":"Altenburger","year":"1989","journal-title":"Arch. Virol."},{"issue":"Pt 2","key":"10.1016\/j.micinf.2005.10.004_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"79","author":"Drexler","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.micinf.2005.10.004_bib36","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.micinf.2005.10.004_bib37","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JVI.74.2.923-933.2000","article-title":"Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine","volume":"74","author":"Ramirez","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.micinf.2005.10.004_bib38","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behaviour in organisms with a debilitated defence mechanism (author's transl)","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl. Bakteriol. B"},{"key":"10.1016\/j.micinf.2005.10.004_bib39","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1432-1327.1999.00122.x","article-title":"Molecular cloning, cell localization and binding affinity to DNA replication proteins of the p36\/LACK protective antigen from Leishmania infantum","volume":"259","author":"Gonzalez-Aseguinolaza","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.micinf.2005.10.004_bib40","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1073\/pnas.85.5.1667","article-title":"Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals","volume":"85","author":"Rodriguez","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.micinf.2005.10.004_bib41","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.4049\/jimmunol.172.10.6209","article-title":"Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule","volume":"172","author":"Gherardi","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.micinf.2005.10.004_bib42","first-page":"3403","article-title":"Vaccinia virus expression vector: co expression of beta-galactosidase provides visual screening of recombinant virus plaques","volume":"5","author":"Chakrabarti","year":"1985","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.micinf.2005.10.004_bib43","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1286-4579(01)01426-5","article-title":"Protective immune response against cutaneous leishmaniasis by prime\/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36\/LACK and IL-12 in combination with purified p36","volume":"3","author":"Gonzalo","year":"2001","journal-title":"Microbes. Infect."},{"key":"10.1016\/j.micinf.2005.10.004_bib44","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/AAC.39.9.2167","article-title":"Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice","volume":"39","author":"Buffet","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micinf.2005.10.004_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.iy.13.040195.001055","article-title":"The regulation of immunity to Leishmania major","volume":"13","author":"Reiner","year":"1995","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.micinf.2005.10.004_bib46","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1128\/iai.62.6.2614-2618.1994","article-title":"Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis","volume":"62","author":"Da-Cruz","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2005.10.004_bib47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1590\/S0074-02762000000200012","article-title":"Cell populations in lesions of cutaneous leishmaniasis of Leishmania (L.) amazonensis-infected rhesus macaques, Macaca mulatta","volume":"95","author":"Amaral","year":"2000","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.micinf.2005.10.004_bib48","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/intimm\/3.6.587","article-title":"Establishment of resistance to Leishmania major infection in susceptible BALB\/c mice requires parasite-specific CD8+ T cells","volume":"3","author":"Muller","year":"1991","journal-title":"Int. Immunol."},{"key":"10.1016\/j.micinf.2005.10.004_bib49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0264-410X(02)00450-4","article-title":"DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice","volume":"21","author":"Lopez-Fuertes","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2005.10.004_bib50","first-page":"304","article-title":"TNF-alpha reverses the disease-exacerbating effect of subcutaneous immunization against murine cutaneous leishmaniasis","volume":"74","author":"Liew","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.micinf.2005.10.004_bib51","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/IAI.70.1.240-248.2002","article-title":"Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major","volume":"70","author":"Cote-Sierra","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2005.10.004_bib52","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.4049\/jimmunol.166.6.4012","article-title":"Rapidly fatal leishmaniasis in resistant C57BL\/6 mice lacking TNF","volume":"166","author":"Wilhelm","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.micinf.2005.10.004_bib53","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.8451641","article-title":"TH1 and TH2 cell antigen receptors in experimental leishmaniasis","volume":"259","author":"Reiner","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.micinf.2005.10.004_bib54","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.274.5286.421","article-title":"Resistance to Leishmania major induced by tolerance to a single antigen","volume":"274","author":"Julia","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.micinf.2005.10.004_bib55","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.171.6.3148","article-title":"Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothers","volume":"171","author":"Sedegah","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.micinf.2005.10.004_bib56","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nm881","article-title":"Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans","volume":"9","author":"McConkey","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.micinf.2005.10.004_bib57","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0264-410X(01)00389-9","volume":"20","author":"Gomez","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2005.10.004_bib58","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00262-004-0616-7","article-title":"A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)","volume":"54","author":"Meyer","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.micinf.2005.10.004_bib59","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4049\/jimmunol.165.2.915","article-title":"Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells","volume":"165","author":"Gurunathan","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.micinf.2005.10.004_bib60","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/S0264-410X(02)00189-5","article-title":"Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB\/c mice: the partial protection relies on interferon gamma producing CD8 (+) T lymphocyte activation","volume":"20","author":"Rafati","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2005.10.004_bib61","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1590\/S0001-37652003000400005","article-title":"Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines","volume":"75","author":"Rodrigues","year":"2003","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.micinf.2005.10.004_bib62","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1471-4906(01)01975-5","article-title":"Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways","volume":"22","author":"Jankovic","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.micinf.2005.10.004_bib63","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-3083.1999.00554.x","article-title":"Interferon-gamma- and tumour necrosis factor-alpha-producing cells in humans who are immune to cutaneous leishmaniasis","volume":"49","author":"Kemp","year":"1999","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.micinf.2005.10.004_bib64","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1128\/IAI.73.8.5286-5289.2005","article-title":"Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis","volume":"73","author":"Dondji","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2005.10.004_bib65","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"Kaye","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.micinf.2005.10.004_bib66","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/iai.62.3.1058-1063.1994","article-title":"Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis","volume":"62","author":"Miralles","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2005.10.004_bib67","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1128\/JVI.78.11.5820-5834.2004","article-title":"Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells","volume":"78","author":"Guerra","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.micinf.2005.10.004_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/clinchem\/45.1.7","article-title":"New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases","volume":"45","author":"Chen","year":"1999","journal-title":"Clin. Chem."}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457905003722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457905003722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:17:20Z","timestamp":1761142640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457905003722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1286457905003722"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2005.10.004","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2005.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}